Evidence map›Paper›PMID 38868647›Full record

ArticlePCN reports : psychiatry and clinical neurosciences2022

Mania after long-term treatment with daily 10 mg prednisolone.

Rintaro Fujii, Yuki Konishi, Ryutaro Furusawa, Naomichi Okamoto, Reiji Yoshimura

Abstract readCase Reports
In one paragraph

Article in PCN reports : psychiatry and clinical neurosciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Mania after long-term treatment with daily 10 mg prednisolone.PCN reports : psychiatry and clinical neurosciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Rintaro FujiiDepartment of Psychiatry University of Occupational and Environmental Health Yahatanishiku Kitakyushu Japan.ORCID 0000-0001-5487-7068
Yuki KonishiDepartment of Psychiatry University of Occupational and Environmental Health Yahatanishiku Kitakyushu Japan.
Ryutaro FurusawaDepartment of Psychiatry University of Occupational and Environmental Health Yahatanishiku Kitakyushu Japan.
Naomichi OkamotoDepartment of Psychiatry University of Occupational and Environmental Health Yahatanishiku Kitakyushu Japan.ORCID 0000-0003-2791-8113
Reiji YoshimuraDepartment of Psychiatry University of Occupational and Environmental Health Yahatanishiku Kitakyushu Japan.ORCID 0000-0002-7637-5576

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: High-dose corticosteroids may be accompanied by central nervous system side-effects, including psychiatric disorders. These psychiatric disorders tend to appear relatively early in treatment. We report an unusual case of mania after long-term administration of a small dose of prednisolone. Case Presentation: A patient was treated for relapsed Crohn's disease with a small dose of prednisolone (10 mg/day). After 6 months, she became severely manic. There was no family history of psychiatric disorders. The mania was resistant to olanzapine and sodium valproate, but improved with the reduction of the prednisolone dose. Prednisolone was tapered off while confirming with the gastroenterologist that there was no flare-up of Crohn's disease. She is now off prednisolone and is doing well, with no outbreaks of Crohn's disease or manic episodes. Conclusion: This case of severe mania after 6 months of low-dose prednisolone is unusual. Physicians should be aware that even small doses of long-term prednisolone may cause the emergence of severe mania.

Indexed as

corticosteroidlong termlow dosemaniaprednisolone

Identifiers

PMID38868647
PMCPMC11114336

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.